To investigate whether Dicer expression levels correlate with VHL-deficient ccRCC patient survival, we followed up with 146 ccRCC patients with VHL mutations or promoter methylation for 1–52 months (median, 39 months). The gene discussed is VHL; the disease is nonpapillary renal cell carcinoma.